Dow Jones

39,841.20

0.72%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

AVN.R

Avanir (AVN.R)

Avanir Pharmaceuticl

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AVN.R

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
11/04/2006	07:00	Business Wire	AVANIR Stock to Commence Trading on the NASDAQ National Market System	AMEX:AVN.R	Avanir Pharmaceuticl
04/04/2006	07:00	Business Wire	AVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder	AMEX:AVN.R	Avanir Pharmaceuticl
03/04/2006	15:15	Business Wire	AVANIR to Change Listing to the NASDAQ National Market System; Trading will Commence on April 11, Under the Ticker Symbol AVNR	AMEX:AVN.R	Avanir Pharmaceuticl
29/03/2006	15:15	Business Wire	AVANIR Pharmaceuticals Invites Investors to Listen to the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals C	AMEX:AVN.R	Avanir Pharmaceuticl
01/03/2006	15:15	Business Wire	AVANIR Pharmaceuticals Hires Matthew R. Ruth as Vice President of Sales	AMEX:AVN.R	Avanir Pharmaceuticl
09/02/2006	15:05	Business Wire	AVANIR Pharmaceuticals Reports First Quarter of Fiscal Year 2006 Results	AMEX:AVN.R	Avanir Pharmaceuticl
06/02/2006	15:15	Business Wire	AVANIR Receives Approximately $4.2 Million from Exercise of Warrants	AMEX:AVN.R	Avanir Pharmaceuticl
06/02/2006	11:15	Business Wire	AVANIR Pharmaceuticals Holds Annual Meeting of Shareholders	AMEX:AVN.R	Avanir Pharmaceuticl
30/01/2006	05:00	Business Wire	AVANIR Submits Expanded Neurodex New Drug Application for the Treatment of Involuntary Emotional Expression Disorder	AMEX:AVN.R	Avanir Pharmaceuticl
18/01/2006	10:25	Business Wire	CORRECTING and REPLACING AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Thursday, February 9,	AMEX:AVN.R	Avanir Pharmaceuticl
18/01/2006	07:30	Business Wire	AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on February 9, 2006	AMEX:AVN.R	Avanir Pharmaceuticl